People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Software / Tech, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Netsertive, Inc. | — | Other Technology | Series B | $46.5M | $730.9M | 2012 |
| Ceterus, Inc. | — | Other Technology | Series A | $31.3M | $49.9M | 2018 |
| Springbot, Inc. | — | Other Technology | Series A | $28.2M | $61.4M | 2016 |
| Racemi, Inc | — | Other Technology | Series A | $16.9M | $166.4M | 2012 |
| Leven Labs, Inc. | — | Software / Tech | Series A | $15.5M | $65.5M | 2024 |
| Privaris Inc | — | Other Technology | Seed | $13.4M | $108.1M | 2009 |
| Unitrends Inc | — | Business Services | Seed | $3.5M | $88.9M | 2010 |
| Yap Inc | — | Other Technology | Seed | $1.5M | $51.1M | 2010 |
| Taproot Systems Inc | — | Other Technology | Pre-Seed | $300K | $12.7M | 2010 |
| NSB Marketing, Inc. | — | Other Technology | Pre-Seed | $250K | $3.0M | 2022 |
Wayne Hunter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wayne Hunter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Philip Eliot | 2 | 6 |
| David Coit | 2 | 5 |
| Allen Nance | 2 | 3 |
| Mark Johnson | 1 | 22 |
| Brian Gallagher | 1 | 11 |
| Sean Ammirati | 1 | 11 |
| Barry Johnson | 1 | 10 |
| Brian Carney | 1 | 10 |
| Mitch Mumma | 1 | 8 |
| David Gould | 1 | 7 |
| James D. Robinson IV | 1 | 7 |
| Glen Bressner | 1 | 6 |
| Said Mohammadioun | 1 | 6 |
| James Robinson | 1 | 6 |
| Scott Albert | 1 | 5 |
| John Vecchio | 1 | 4 |
| Edward McCarthy | 1 | 3 |
| Wayne L. Hunter | 1 | 3 |
| MARK CAMPBELL | 1 | 3 |
| Derek Carter | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.